by conventional karyotyping, identifying a large Xp22 duplication causing an Xp functional disomy. Family studies found that this duplication was inherited from the proband's mother and was also present in one of his sisters. This sister had conventional karyotyping performed during pregnancy with a normal result. Postnatally, her child, the proband's nephew, presented with autism spectrum disorders. aCGH revealed a 339-kb IL1RAPL1 duplication. Overall, the proband, his mother, and one of his sisters all harboured both Keywords Genetic counselling · IL1RAPL1 duplication · Intellectual disability · Meiotic recombination · X chromosome
CNVs, while his other sister and the 2 sons of each sister only carried the IL1RAPL1 intragenic duplication. As seen in this family, we emphasise the importance of small CNV detection, the pathogenicity of IL1RAPL1 exonic duplications in male carriers, and the difficulties for genetic counselling with the risk of double diagnosis in a single patient.
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Using whole-genome sequencing, Gilissen et al. [2014] estimated that 62% of the cases of severe intellectual disability (ID) have a genetic background. ID affects between 1.5 and 2% of the population in Western countries, especially among males [Leonard and Wen, 2002] . The high prevalence among males could be due to the location of the genes involved in ID in the X chromosome. Variants in genes located in the X chromosome are expected to account for about 10% of all male cases of ID [Ropers, 2008 [Ropers, , 2010 Gécz et al., 2009] . More than 100 genes have already been identified in X-linked ID. Among these, IL1RAPL1, located in the Xp21.2 chromosomal region, is mainly expressed in cerebral structures involving memory and encodes a 696-amino acid transmembrane protein involved in spinogenesis [Hayashi et al., 2013] . It is now well recognised that mutations in IL1RAPL1 are associated with non-syndromic ID and autism spectrum disorders [Piton et al., 2008] .
In this report, we present a family with several males with different degrees of ID. Cytogenetic investigation identified 2 duplications located in the same X chromosome. A large Xp22.31p22.12 duplication was first identified by standard karyotype analysis. Years later, a small intragenic IL1RAPL1 duplication was found using array CGH (aCGH), once again demonstrating the superiority of aCGH compared to karyotyping in the diagnosis of developmental disorders [Hochstenbach et al., 2009; Miller et al., 2010] . In this family, segregation of these Xp copy number variations (CNVs) was modified over 2 generations explaining different phenotypes in males and leading to errors in genetic counselling.
Case Reports
The pedigree of the family is shown in Figure 1 .
Patient II.5
Patient II.5 was the first to be addressed for genetic testing. This 44-year-old patient had profound ID. His head circumference at birth was 33 cm (10th percentile). He had delayed developmental milestones with hypotonia and strabismus. He walked at 2.5 years of age and had no verbal skills with very poor interaction skills. He walked with a slightly broad-based gait and had stereotyped movements. He had a very quiet personality. Dysmorphic features included pectus excavatum, hypertelorism, epicanthus, a flat nasal bridge, arched eyebrows, retrognathia, fleshy lips, and large ears ( Fig. 2 ) .
Patient III.1
This 11-year-old boy was born at term after an uneventful pregnancy. At birth, his weight was 3,415 g (40th percentile), height was 52 cm (75th percentile), and head circumference was 36 cm (50th percentile). Apgar score was 10/10. Early psychomotor development was slightly delayed. He walked at 17 months of age. He had moderate fine motor impairment and early social interaction problems contrasting with normal language acquisition. He needed sameness of environment and had perseverative behaviour, with a low frustration tolerance. He was diagnosed with visuospatial dyspraxia and attention deficit at 6.5 years of age as well as Asperger syndrome (using the ADOS and ADI-R scales) at 7 years of age. On the WISC-IV, at 10 years of age, on methylphenidate 15 mg per day, his verbal comprehension index was 86, perceptual reasoning index was 52, working memory index was 60, and processing speed index was 59. On clinical examination, he had no neurological or dysmorphic features. EEG and brain MRI, performed respectively at 6 and 8 years of age, were normal. Fragile X genetic analysis and metabolic screening (T3-T4-TSH, urinary organic acids, orotic acid, creatinine, and guanidinoacetate, blood aminoacids) were normal.
Patient III.5
This 6.5-year-old child was born after an uneventful pregnancy. At birth, weight was 3,320 g (35th percentile), height was 50 cm (50th percentile), and head circumference was 36.5 cm (64th percentile). Early psychomotor development was normal. He walked at 15 months, and language started at 18 months. He had mild problems with social interaction, but did not meet criteria for pervasive developmental disorder on autism-standardised scales. At school age, he was diagnosed with dyspraxia and attention deficit with hyperactivity, which improved on methylphenidate 20 mg per day. On the WISC-IV, at 6.5 years of age, his verbal comprehension index was 96, perceptual reasoning index was 67, working memory index was 60, and processing speed index was 50. On clinical examination, he had no neurological or dysmorphic features, except pes planus.
Methods

Karyotyping
Standard GTG-and RHG-banded karyotypes obtained from peripheral blood were determined for patient II.5 using standard procedures.
Array CGH
QIAamp DNA Blood Midikit (Qiagen, Courtaboeuf, France) was used for DNA extraction. Oligonucleotide aCGH was performed with an 180,000-oligonucleotide microarray (SurePrint G3 Human CGH Microarray Kit, 4×180K, AMADID: 022060, Agilent Technologies, Santa Clara, CA, USA). The median probe spacing of this microarray is about 13 kb. The aCGH procedures were performed in accordance with the manufacturer's instructions. The 180K slides were scanned on an Agilent DNA Microarray Scanner and images were extracted with Feature Extraction software (10.7.3.1). Data analysis was carried out with Genomic Workbench 5.0.14 software (Agilent Technologies). The following parameters were used for interpretation: ADM-2, threshold: 5.0, window: 0.2 Mb, cutoff: 0.25. A CNV was validated if an abnormal log 2 ratio was obtained for at least 3 contiguous probes. The aCGH results were analysed using the UCSC hg19 assembly (https://genome-euro.ucsc.edu/).
Quantitative PCR Quantitative PCR (qPCR) was performed on genomic DNA, with 2 primer pairs amplifying unique sequences within IL1RAPL1 and within ADORA2B as the reference gene and the QuantiTect SYBR Green PCR Kit (Qiagen). Experiments were conducted on a Light Cycler 2000 (Roche Applied Science, Indianapolis, IN, USA).
Haplotype Analysis
Microsatellite markers spread throughout the X chromosome and particularly covering the 2 regions of interest were studied (from Xp telomere to centromere): DXS7107, DXS996, DXS8051, DXS987, DXS8019, DXS365, DXS1226, DXS989, DXS8056, DXS6742, DXS1202, DXS1214, DXS8090, and DXS8054. X-chromosome inactivation was studied by the methyl-PCR method at the FMR1 locus using an in-house protocol and after treatment of DNA by the EpiTect Bisulfite kit (Qiagen). Fragment analyses were run on a sequencing machine CEQ-2000XL (Beckman Coulter, Brea, CA, USA). 
Results
Chronologically, several years ago, standard karyotype analysis for patient II.5 showed an Xp22.31p22.12 duplication, 46,Y,dup(X)(p22.31p22.12); aCGH was not an established method at this time. His mother (I.1) and one of his sisters (II.1) were asymptomatic carriers, whereas the other sister (II.3) had a normal karyotype. Consequently, a prenatal exploration by chorionic villus sampling was proposed and performed during pregnancy of patient II.1. The Xp22.31p22.12 duplication was not found by standard karyotyping, leading to a reassuring genetic counselling. However, postnatally, aCGH performed in patient III.1 because of psychomotor delay and behaviour troubles, found a 339-kb duplication in Xp21.2. This intragenic duplication encompasses exons 4 and 5 of IL1RAPL1 , arr[GRCh38] Xp21.2(29318390_29657768)×2. qPCR and/or aCGH analysis showed that his mother (II.1), his aunt (II.3), his cousin (III.5), and his grandmother (I.1) were all carriers of this duplication, just as the proband (II.5). All other male patients of the family, who had no neurodevelopment impairment, were not carriers of this Xp21.2 duplication. aCGH also delineated the Xp22.31p22.12 duplication to 11.8 Mb between the positions 7666592 and 19446130 (GRCh38) . This large duplication spans 59 genes, including 15 pathogenic OMIM genes (http://www.omim.org/). Patients I.1 and II.1, both harbouring the large Xp22.31p22.12 duplication, had complete skewed Xchromosome inactivation (0: 100%), whereas patient II.3 (carrying only the IL1RAPL1 duplication) had a normal X-chromosome inactivation pattern.
Microsatellite analysis found that in I.1, II.1, and II.5, the 2 CNVs were located in the same X chromosome and that a double crossing-over had occurred during grandmaternal meiosis in patient II.3, both upstream and downstream of the large Xp22.31p22.12 duplication. During meiosis in patient II.1, a simple recombination occurred between the markers DXS365 and DXS1226, leading to a chromosome without a large Xp22 duplication in patient III.1, but in which the IL1RAPL1 duplication was maintained (data not shown).
Discussion
The clinical features seen in patient II.5 could be explained by the 11.8-Mb Xp22.31p22.12 duplication leading to a functional Xp22 disomy. Indeed, the patient presents with the key phenotypic features related to Xp functional disomy as described by Hunter et al. [2009] : cognitive impairment, hypotonia, hypertelorism, and ear abnormalities. Considering the 59 genes duplicated, it is difficult to obtain a precise genotype/phenotype correlation for each phenotypic trait as it has already been the case in similar findings of large Xp functional disomies [Lintas et al., 2016] . However, among others, we could note the presence of a single CDKL5 gene, while CDKL5 duplications have already been reported as being responsible for autistic behaviour and development and speech delay in both males and females in case of random X-chromosme inactivation [Szafranski et al., 2015] . We observed complete skewed X-chromosome inactivation in both female carriers of this duplication (patients I.1 and II.1). The 2 male patients of this family presenting with the same isolated intragenic IL1RAPL1 duplication (III.1and III.5) share a similar phenotype, including autism spectrum disorders, short attention span, and dyspraxia without ID as well as dysmorphic features. Froyen et al. [2007] and Zhang et al. [2009] both reported a case of IL1RAPL1 duplication associated with ID, but in both cases, the CNV encompassed other XLID genes such as CASK and DMD. Four patients in the DECIPHER database (274669, 277292, 249698 and 280583; https://decipher.sanger.ac.uk/) harbour an overlapping intragenic IL1RAPL1 duplication. They all present with developmental delay as patients from the database harbouring an overlapping deletion.
Interestingly, 2 apparently unrelated Japanese families carrying 2 CNVs close to those found in the family presented herein, namely a 737-kb duplication in Xp22.2 (chrX:16880008-17617255 [GRCh38] ) and a 100-kb duplication in IL1RAPL1 in Xp21.3 (chrX:28693477-28793925 [GRCh38] ), have been reported by Honda et al. [2010] These patients harboured variable clinical phenotypes: autistic features and speech delay with moderate ID for the first family and West syndrome with absent speech and severe ID for the second one. Using hg38 UCSC Genome Browser (http://grch37.ensembl.org/index.html), no repeated genomic elements potentially promoting rearrangements at breakpoint loci were found, and there is no argument for a recurrent mechanism for the 2 duplications. Finally, Utine et al. [2014] reported a small IL1RAPL1 duplication also encompassing exons 4 and 5 in a patient with syndromic developmental delay and microcephaly, corpus callosum agenesis, short stature, and facial dysmorphism. He was born to consanguineous parents, raising the risk for an additional unknown diagnosis which could explain the phenotypic differences compared to other patients carrying IL1RAPL1 variants [Utine et al., 2014] .
The X-linked Mental Retardation 21 OMIM phenotype linked to IL1RAPL1 alterations (OMIM 300143) is defined by variable ID and possible additional features such as facial dysmorphism and autistic traits. RamosBrossier et al. [2015] have demonstrated that a loss-offunction mechanism impairing synaptogenesis was consecutive to 2 different single nucleotide variations and an exonic deletion. We hypothesise that this intragenic IL1RAPL1 duplication leads to haploinsufficiency, either by a truncation or by a conformational change in the protein, as described for other genes [Liedén et al., 2014; Schwaibold et al., 2014] . It is of note that in silico reconstruction of tandem duplication of exons 4 and 5 (NM_014271.3(IL1RAPL1_v001):c.363_703dup) leads to a premature stop codon.
In 2012, Jobanputra et al. addressed the question of the influence of CNVs in the X-chromosome inactivation process. The authors suggest that even if skewed Xchromosome inactivation can rarely be related to a CNV, the size of the CNV may influence the X-inactivation ratio. Larger CNVs seemed to be more frequently associated with complete skewed X inactivation than small CNVs, whatever the precise gene content is. This is consistent with the family reported herein, in which the 2 females bearing the large CNV in the X chromosome (I.1 and II.1) had a complete skewed X-chromosome inactivation, whereas patient II.3, bearing only the small intragenic IL1RAPL1 CNV, had random X inactivation. This has also been recently reported in another family with intragenic IL1RAPL1 duplication [Laino et al., 2016] .
One important aspect for genetic counselling based on this familial observation is the risk of a double molecular event as it has been described by exome sequencing; 1.4% of the patients have more than a single molecular diagnosis [Yang et al., 2014] . Indeed, the large Xp22 duplication explained the phenotype of patient II.5 and was logically targeted for familial inquiry and prenatal testing thereafter. However, the result obtained by conventional karyotype analysis was insufficient for appropriate genetic counselling. An aCGH would have revealed the risk of occurrence of the 2 CNVs in the offspring, suggesting adequate prenatal genetic testing.
In practice, the occurrence of a second pathogenic CNV or even another pathogenic variation and possible meiotic recombinations in a family must be kept in mind for genetic investigations and counselling.
Statement of Ethics
Experiments were conducted in accordance with the Declaration of Helsinki. All procedures were carried out with the adequate understanding, and written informed consent was obtained from the patients or their parents.
Disclosure Statement
The authors declare no conflicts of interest.
